Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för mercaptopurine. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

10 träffar

Bibliografisk träff 2017-07-01

Safety of azathioprine and 6-mercaptopurine in patients with inflammatory bowel disease naïve to thiopurine treatment .

Alaish R, Lundgren D, Suhr OB, Werner M, Karling P.

Int J Clin Pharmacol Ther · comparative study; journal article; observational study · DOI 10.5414/cp202962

Bibliografisk träff 2017-06-01

6-mercaptopurine promotes energetic failure in proliferating T cells.

Fernández-Ramos AA, Marchetti-Laurent C, Poindessous V, Antonio S, Laurent-Puig P, Bortoli S, Loriot MA, Pallet N.

Oncotarget · research-article; journal article · DOI 10.18632/oncotarget.17889

Bibliografisk träff 2017-04-18

Interaction between NUDT15 and ABCC4 variants enhances intolerability of 6-mercaptopurine in Japanese patients with childhood acute lymphoblastic leukemia.

Tanaka Y, Nakadate H, Kondoh K, Nakamura K, Koh K, Manabe A.

Pharmacogenomics J · research support, non-u.s. gov't; multicenter study; journal article · DOI 10.1038/tpj.2017.12

Bibliografisk träff 2017-04-12

Ordinary differential equations and Boolean networks in application to modelling of 6-mercaptopurine metabolism.

Lavrova AI, Postnikov EB, Zyubin AY, Babak SV.

R Soc Open Sci · research-article; journal article · DOI 10.1098/rsos.160872

Bibliografisk träff 2017-03-29

Comparison of 6-mercaptopurine with 6-thioguanine for the analysis of thiopurine S-methyltransferase activity in human erythrocyte by LC-MS/MS.

Mei S, Li X, Gong X, Zhang X, Li X, Yang L, Zhu L, Zhou H, Liu Y, Zhou A, Zhang X, Zhao Z.

Biomed Chromatogr · journal article · DOI 10.1002/bmc.3959

Bibliografisk träff 2017-03-10

Pharmacokinetics of two 6-mercaptopurine liquid formulations in children with acute lymphoblastic leukemia.

Tolbert JA, Bai S, Abdel-Rahman SM, August KJ, Weir SJ, Kearns GL, Neville KA.

Pediatr Blood Cancer · randomized controlled trial; journal article · DOI 10.1002/pbc.26465

Bibliografisk träff 2017-03-01

Successful Treatment of Generalized Essential Telangiectasia With 6-Mercaptopurine.

Glazer AM, Sofen BD, Rigel DS, Shupack JL.

J Drugs Dermatol · journal article; case reports

Bibliografisk träff 2017-02-06

Drugs and drug-like molecules can modulate the function of mucosal-associated invariant T cells.

Keller AN, Eckle SB, Xu W, Liu L, Hughes VA, Mak JY, Meehan BS, Pediongco T, Birkinshaw RW, Chen Z, Wang H, D'Souza C, Kjer-Nielsen L, Gherardin NA, Godfrey DI, Kostenko L, Corbett AJ, Purcell AW, Fairlie DP, McCluskey J, Rossjohn J.

Nat Immunol · research support, non-u.s. gov't; journal article · DOI 10.1038/ni.3679

Bibliografisk träff 2016-12-21

NK cells are biologic and biochemical targets of 6-mercaptopurine in Crohn's disease patients.

Yusung S, McGovern D, Lin L, Hommes D, Lagishetty V, Braun J.

Clin Immunol · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1016/j.clim.2016.12.004

Bibliografisk träff 2005-12-01

The thiopurines: an update.

Coulthard S, Hogarth L.

Invest New Drugs · research support, non-u.s. gov't; review; journal article · DOI 10.1007/s10637-005-4020-8